Published on GHDx (https://ghdx.healthdata.org.)

Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

General Info

Geography 
Global
Time period covered 
January, 2013 - December, 2016
Data type
Scientific literature
Keywords 
Cholesterol, Heart failure, Ischemic heart disease, Stroke

Citation

Authors 
Nicholls SJ, Puri R, Anderson T, Ballantyne CM, Cho L, Kastelein JJ, Koenig W, Somaratne R, Kassahun H, Yang J, Wasserman SM, Scott R, Ungi I, Podolec J, Ophuis AO, Cornel JH, Borgman M, Brennan DM, Nissen SE
Journal 
JAMA
Pages 
2373-2384
Publication year 
2016
Suggested citation 
Nicholls SJ, Puri R, Anderson T, Ballantyne CM, Cho L, Kastelein JJ, Koenig W, Somaratne R, Kassahun H, Yang J, Wasserman SM, Scott R, Ungi I, Podolec J, Ophuis AO, Cornel JH, Borgman M, Brennan DM, Nissen SE. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. JAMA. 2016; 316(22): 2373-2384.
Source URL:https://ghdx.healthdata.org./record/effect-evolocumab-progression-coronary-disease-statin-treated-patients-glagov-randomized#comment-0